Celgene (CELG) Reports Solid Q2 Results; Raises FY10 Sales Outlook
CELG Hot Sheet
EPS Growth %: +30.1%Financial Fact:
Income before income taxes: 474M
Today's EPS Names:
TARO, BRLI, TLB, More
Celgene (Nasdaq: CELG) reports Q2 EPS of $0.69, ex-items, 3 cents better than the analyst estimate of $0.66. Revenue for the quarter was $850.4 million, which compares to the estimate of $820.42 million.
Raises its FY10 sales guidance from $3.3-$3.4 billion to $3.4-$3.45 billion, which compares to the Street estimate of $3.36 billion.
Raises its FY10 sales guidance from $3.3-$3.4 billion to $3.4-$3.45 billion, which compares to the Street estimate of $3.36 billion.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- AFC Enterprises, Inc. (AFCE) Tops Q1 EPS by 4c; Raises FY12 Comps Outlook
- Rue21, Inc. (RUE) Tops Q1 EPS by 3c; Boosts FY12 EPS Outlook; Approves $50M Buyback
Create E-mail Alert Related Categories
Earnings, Guidance, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
